Development and profiling of Pseudomonas aeruginosa LasB inhibitors as novel antivirulence agents – LasBAntiv

Jean-michel Sallenave (INSERM U1152 Université Paris Diderot)

The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.

INSERM U1152 Université Paris Diderot
Helmholtz-Zentrum für Infektionsforschung GmbH
Helmholtz-Zentrum für Infektionsforschung GmbH
CNRS AMU LCB UMR7283
Helmholtz-Zentrum für Infektionsforschung GmbH

Help of the ANR 489,269 euros
Beginning and duration of the scientific project: February 2021 - 36 Months

• List of selected projects
• Permanent link to this summary on the ANR website (ANR-20-AMRB-0007)
• See the publications in the HAL-ANR portal